Get started
Author

Fiona T. Bane

Observed names: Bane, Fiona, Fiona Bane, Fiona T Bane
ORCID: 0000-0003-4213-1474
Observed ORCID: 0000-0003-4213-1474
OpenAlex ID: A5112583053
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
2022 · Nicola Cosgrove, Damir Varešlija, et al. · Nature Communications · 91
PDF
Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence
2009 · Aisling M. Redmond, Fiona T. Bane, et al. · Clinical Cancer Research · 91
NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
2014 · Li Qin, Ye-Lin Wu, et al. · Cancer Research · 61
AIB1:ERα Transcriptional Activity Is Selectively Enhanced in Aromatase Inhibitor–Resistant Breast Cancer Cells
2012 · Jane O'Hara, Damir Vareslija, et al. · Clinical Cancer Research · 41
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
2018 · Alacoque L. Browne, Sara Charmsaz, et al. · Oncogene · 40
PDF
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy
2015 · Jean McBryan, Ailís Fagan, et al. · Clinical Cancer Research · 35
The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2
2010 · Dara O Kavanagh, Marie McIlroy, et al. · Endocrine Related Cancer · 33
PDF
S100β as a serum marker in endocrine resistant breast cancer
2017 · Sara Charmsaz, Éamon Hughes, et al. · BMC Medicine · 30
PDF
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
2021 · Damir Varešlija, Elspeth Ward, et al. · Oncogene · 28
PDF
ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
2020 · Sara Charmsaz, Ben Doherty, et al. · BMC Medicine · 17
PDF
The Microtubule-Targeting Agents, PBOX-6 [Pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and Paclitaxel, Induce Nucleocytoplasmic Redistribution of the Peptidyl-Prolyl Isomerases, Cyclophilin A and Pin1, in Malignant Hematopoietic Cells
2009 · Fiona T. Bane, John H. Bannon, et al. · Journal of Pharmacology and Experimental Therapeutics · 13
RET overexpression leads to increased brain metastatic competency in luminal breast cancer
2024 · Petra Jagust, Aoibhin M Powell, et al. · JNCI Journal of the National Cancer Institute · 12
Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy
2019 · Laura Creevey, Rachel Bleach, et al. · Molecular Cancer Therapeutics · 12
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer
2023 · Stephen Keelan, Mihaela Ola, et al. · 癌症：英文版 · 11
PDF
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer
2025 · Daniela Ottaviani, Mihaela Ola, et al. · JNCI Journal of the National Cancer Institute · 6
Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers
2024 · Gavin P. Dowling, Gordon R. Daly, et al. · 癌症：英文版 · 6
PDF
Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
2025 · Sara Charmsaz, Ben Doherty, et al. · BMC Medicine
PDF
133 Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancer
2025 · Gordon R Daly, Gavin P Dowling, et al. · British journal of surgery
PDF
AB086. SOH25_AB_359. Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancer
2025 · Gordon Daly, Gavin Dowling, et al. · Mesentery and Peritoneum
ERRATUM: The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2
2024 · Dara O Kavanagh, Marie McIlroy, et al. · Endocrine Related Cancer
AB026. SOH24AB_045. Knowledge of BRCA1/BRCA2 pathogenic variant status in a non-Ashkenazi Jewish cohort is important for survival
2024 · Aisling Hegarty, Gavin Dowling, et al. · Mesentery and Peritoneum
Cover Image, Volume 43, Issue 5
2023 · Stephen Keelan, Mihaela Ola, et al. · 癌症：英文版
PDF
Supplementary Figure 2 from Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy
2023 · Laura Creevey, Rachel Bleach, et al.
Supplemental Figure 6 from Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy
2023 · Laura Creevey, Rachel Bleach, et al.
Supplemental Tables from Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy
2023 · Laura Creevey, Rachel Bleach, et al.
Works count: 95
Citation count: 527
H-index: 12
I10-index: 14
Year
Topic
Type